I played over 10 years in the NBA and made tens of millions of dollars. I had everything I ever dreamed of. But after a series of legal issues and personal problems, my life has become something I could never have imagined. I'm right back to where it all began - back in Coney Island, back in the projects, back in the fire.
Despite ushering in the weight-loss injectable craze and reaching a whopping $604 billion market cap in March 2024, Novo has for the past 18 months suffered hit after financial hit as compounding companies cut into its profit margin by selling cheaper, off-brand Ozempic - and as Eli Lilly, the makers of rival jabs Mounjaro and Zepbound, surged ahead thanks to promising news about its orforglipron GLP-1 pill.
